Personalized Medicines In Oncology Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Personalized Medicines In Oncology Market
Personalized Medicines In Oncology Market: By Tumor (Genomics, Proteomics, Metabolomics) End User (Hospitals, Research Centers, Governmental institutions) Technology (Next-Generation Sequencing, PCR, Others) By Occurrence - Forecast(2018 - 2023)
Report Code : HCR 0097
Updated Date: 20 February, 2018  
5

Copies sold

    Client Rating

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Market Overview
2. Executive Summary
3. Personalized Medicines In Oncology Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Personalized Medicines In Oncology Forces
   4.1. Market Drivers
   4.2. Market Constraints & Challenges
   4.3. Attractiveness of the Personalized Medicines In Oncology Market
      4.3.1. Power of Suppliers
      4.3.2. Threats From New Entrants
      4.3.3. Power of Buyer
      4.3.4. Threat From Substitute Product
      4.3.5. Degree of Competition
5. Personalized Medicines In Oncology -Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunity Analysis
   5.4. Product Life Cycle
   5.5. Suppliers and Distributors
6. Personalized Medicines In Oncology- By Tumore Type
   6.1. Genomics
   6.2. Proteomics
   6.3. Metabolomics
   6.4. Epigenetics
7. Personalized Medicines In Oncology- By Service
   7.1. Molecular Oncopathology
   7.2. Genome Diagnostics
   7.3. Radiation Therapy
   7.4. Oncology Testing
   7.5. Chemotherapy
   7.6. Others
8. Personalized Medicines In Oncology- By Occurence
   8.1. Colorectal/ stomach/ esophageal
   8.2. Ovarian
   8.3. Lung
   8.4. Brest
   8.5. Sarcoma
   8.6. Pancreatic
   8.7. Cancer
   8.8. Mesothelioma
   8.9. Others
9. Personalized Medicines In Oncology- By Technology
   9.1. Next-Generation Sequencing
   9.2. Fluorescence/ Chromogenic In Situ Hybridization
   9.3. Immunohistochemistry
   9.4. Microarray
   9.5. Quantitative PCR
   9.6. High Throughput SNP Analysis
   9.7. Others
10. Personalized Medicines In Oncology- By End User
   10.1. Research Centers
   10.2. Governmental Institutions
   10.3. Hospitals
   10.4. others
11. Personalized Medicines In Oncology- Geography
   11.1.  Americas
      11.1.1. U.S.
      11.1.2. Canada
      11.1.3. Brazil
      11.1.4. Others
   11.2. Europe
      11.2.1. U.K.
      11.2.2. Germany
      11.2.3. Italy
      11.2.4. France
      11.2.5. Others
   11.3. Asia Pacific
      11.3.1. China 
      11.3.2. Japan
      11.3.3. Australia & New Zealand
      11.3.4. Others
   11.4. Rest of The World (RoW)
      11.4.1. Middle East
      11.4.2. Africa
12. Personalized Medicines In Oncology Entropy
   12.1. New Product Developments
   12.2. Product Launches, JVs, Mergers and Acquisitions
13. Company Profiles
   13.1. Agendia Nv
   13.2. Allere Laboratory
   13.3. Alpha Genomix
   13.4. Ariana Pharma
   13.5. Biocrates
   13.6. Biodiscovery
   13.7. Biotheranostics
   13.8. Boreal Genomics, Inc.
   13.9. Caris Life Sciences
   13.10. Chordoma Foundation
   13.11. CompanionDx
   13.12. Cypher Genomics
   13.13. deCode Genetics
   13.14. Diploid
   13.15. DNA Link
   13.16. Edge Bio
   13.17. Foundation Medicine
   13.18. Fulgent Diagnostics
   13.19. Gene TLC
   13.20. GenebyGene
   13.21. Genomic Engenharia Molecular
   13.22. Genomic Health, Inc.
   13.23. Illumina, Inc. 
   13.24. Life Technologies Corporation
   13.25. MapMyGenome
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
14. Appendix

   14.1. Abbreviations
   14.2. Sources
   14.3. Research Methodology
   14.4. Bibliography
   14.5. Compilation of Expert Insights
A Personalized medicine application has the largest network, mainly due to high demand for the effective cancer treatment. Apart from the huge potential of the market in personalized medicine and diagnostic segments; it also has a strong value and the vast expansion opportunities in its application such as biomarker, discovery, cancer and research applications. A number of new tools and services are offered by the various biotechnology medical companies for cancer/tumor profiling which is greatly served a cancer screening and the diagnostic. These tools and services are speeding up the development in the cancer therapeutics field and help in boosting the growth of the personalized medicine market.

A significant tool to achieve Personalized Medicine is the availability of repositories of freely accessible databases. Large databases are formed containing information from genomic, transcriptomic, and proteomic analyses which is available for global access and data processing. Some of these include the Cancer Genome Anatomy Project, the Single Nucleotide Polymorphism Database, in addition to many others. Bioinformatics algorithms can then be used to integrate a patient's clinical information and the genetic profiles of their tumor to predict the relationships of certain molecular changes to the cancer.

Standardization of Personalized medicine includes several characteristics including the type of sample to be analyzed, the suitable methods of sample collection and storage, the selection of the target genes/proteins to be tested, the platform to be used, best experimental conditions, and the interpretation of tests. There are specific quality standards for different laboratories, and test validations will be required with external quality assurance protocols.

There are different approaches and tools available for molecular Personalized Medicine testing. A large array of techniques can be used for Personalized Medicine. Commonly used techniques include PCR, fluorescence in situ hybridization and sequencing. Recently, the completion of the human genome project opened a new opportunities for Personalize Medicine analysis by using high-throughput analysis. These include microarray, mass spectrometry, second-generation sequencing, array comparative genomic hybridization, and high-throughput SNP analysis, among others. A common trend among these tools is their ability to simultaneously analyze hundreds or thousands of targets. This multipara metric approach is likely to improve the sensitivity, specificity, and accuracy of new biomarkers. In addition to acceleration of biomarker discovery, high-throughput analysis allows a better understanding of interaction between different molecules in the pathogenesis of cancer.

Personalized Medicines In Oncology

The overall market generated revenue of $xx m in 2015 and is expected to grow with CAGR of xx% throughout the forecast period to generate $xx m by 2021. The Major players are focusing on marketing their products in emerging markets such as India, Japan, Brazil, and China. Currently Americas and Europe region dominate the overall market by contributing to xx% of the overall revenue. These regions are growing with CAGR of xx% and xx% respectively throughout the forecast period.
 
The Key biotechnology and pharmaceutical companies such as:
  • Caris Life Sciences (U.S.)
  • Proteome Sciences PLC (U.K.)
  • Life Technologies (U.S.)
  • Boreal Genomics, Inc. (U.S.)
  • Oxford Gene Technology Ltd. (OGT) (U.K.)
  • Precision Therapeutics, Inc. (U.S.)

Among others, are undertaking various strategically decisions such as collaborating and partnering with each other as well as with research universities to develop cancer profiling products.
List of Tables

Table 1: Personalized Medicines In Oncology Market Overview 2017-2023
Table 2: Personalized Medicines In Oncology Market Leader Analysis 2017-2018 (US$)
Table 3: Personalized Medicines In Oncology Market Product Analysis 2017-2018 (US$)
Table 4: Personalized Medicines In Oncology Market End User Analysis 2017-2018 (US$)
Table 5: Personalized Medicines In Oncology Market Patent Analysis 2013-2018* (US$)
Table 6: Personalized Medicines In Oncology Market Financial Analysis 2017-2018 (US$)
Table 7: Personalized Medicines In Oncology Market Driver Analysis 2017-2018 (US$)
Table 8: Personalized Medicines In Oncology Market Challenges Analysis 2017-2018 (US$)
Table 9: Personalized Medicines In Oncology Market Constraint Analysis 2017-2018 (US$)
Table 10: Personalized Medicines In Oncology Market Supplier Bargaining Power Analysis 2017-2018 (US$)
Table 11: Personalized Medicines In Oncology Market Buyer Bargaining Power Analysis 2017-2018 (US$)
Table 12: Personalized Medicines In Oncology Market Threat of Substitutes Analysis 2017-2018 (US$)
Table 13: Personalized Medicines In Oncology Market Threat of New Entrants Analysis 2017-2018 (US$)
Table 14: Personalized Medicines In Oncology Market Degree of Competition Analysis 2017-2018 (US$)
Table 15: Personalized Medicines In Oncology Market Value Chain Analysis 2017-2018 (US$)
Table 16: Personalized Medicines In Oncology Market Pricing Analysis 2018-2023 (US$)
Table 17: Personalized Medicines In Oncology Market Opportunities Analysis 2018-2023 (US$)
Table 18: Personalized Medicines In Oncology Market Product Life Cycle Analysis 2018-2023 (US$)
Table 19: Personalized Medicines In Oncology Market Supplier Analysis 2017-2018 (US$)
Table 20: Personalized Medicines In Oncology Market Distributor Analysis 2017-2018 (US$)
Table 21: Personalized Medicines In Oncology Market Trend Analysis 2017-2018 (US$)
Table 22: Personalized Medicines In Oncology Market Size 2017 (US$)
Table 23: Personalized Medicines In Oncology Market Forecast Analysis 2018-2023 (US$)
Table 24: Personalized Medicines In Oncology Market Sales Forecast Analysis 2018-2023 (Units)
Table 25: Personalized Medicines In Oncology Market, Revenue & Volume, By Tumore Type, 2018-2023 ($)
Table 26: Personalized Medicines In Oncology Market By Tumore Type, Revenue & Volume, By Genomics, 2018-2023 ($)
Table 27: Personalized Medicines In Oncology Market By Tumore Type, Revenue & Volume, By Proteomics, 2018-2023 ($)
Table 28: Personalized Medicines In Oncology Market By Tumore Type, Revenue & Volume, By Metabolomics, 2018-2023 ($)
Table 29: Personalized Medicines In Oncology Market By Tumore Type, Revenue & Volume, By Epigenetics, 2018-2023 ($)
Table 30: Personalized Medicines In Oncology Market, Revenue & Volume, By Service, 2018-2023 ($)
Table 31: Personalized Medicines In Oncology Market By Service, Revenue & Volume, By Molecular Oncopathology, 2018-2023 ($)
Table 32: Personalized Medicines In Oncology Market By Service, Revenue & Volume, By Genome Diagnostics, 2018-2023 ($)
Table 33: Personalized Medicines In Oncology Market By Service, Revenue & Volume, By Radiation Therapy, 2018-2023 ($)
Table 34: Personalized Medicines In Oncology Market By Service, Revenue & Volume, By Oncology Testing, 2018-2023 ($)
Table 35: Personalized Medicines In Oncology Market By Service, Revenue & Volume, By Chemotherapy, 2018-2023 ($)
Table 36: Personalized Medicines In Oncology Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 37: Personalized Medicines In Oncology Market By Technology, Revenue & Volume, By Next-Generation Sequencing, 2018-2023 ($)
Table 38: Personalized Medicines In Oncology Market By Technology, Revenue & Volume, By Fluorescence/ Chromogenic In Situ Hybridization, 2018-2023 ($)
Table 39: Personalized Medicines In Oncology Market By Technology, Revenue & Volume, By Immunohistochemistry, 2018-2023 ($)
Table 40: Personalized Medicines In Oncology Market By Technology, Revenue & Volume, By Microarray, 2018-2023 ($)
Table 41: Personalized Medicines In Oncology Market By Technology, Revenue & Volume, By Quantitative PCR, 2018-2023 ($)
Table 42: Personalized Medicines In Oncology Market, Revenue & Volume, By Occurrence, 2018-2023 ($)
Table 43: Personalized Medicines In Oncology Market By Occurrence, Revenue & Volume, By Colorectal/ stomach/ esophageal, 2018-2023 ($)
Table 44: Personalized Medicines In Oncology Market By Occurrence, Revenue & Volume, By Ovarian, 2018-2023 ($)
Table 45: Personalized Medicines In Oncology Market By Occurrence, Revenue & Volume, By Lung, 2018-2023 ($)
Table 46: Personalized Medicines In Oncology Market By Occurrence, Revenue & Volume, By Brest, 2018-2023 ($)
Table 47: Personalized Medicines In Oncology Market By Occurrence, Revenue & Volume, By Sarcoma, 2018-2023 ($)
Table 48: Personalized Medicines In Oncology Market, Revenue & Volume, By End User, 2018-2023 ($)
Table 49: Personalized Medicines In Oncology Market By End User, Revenue & Volume, By Research Centers, 2018-2023 ($)
Table 50: Personalized Medicines In Oncology Market By End User, Revenue & Volume, By Governmental Institutions, 2018-2023 ($)
Table 51: Personalized Medicines In Oncology Market By End User, Revenue & Volume, By Hospitals, 2018-2023 ($)
Table 52: North America Personalized Medicines In Oncology Market, Revenue & Volume, By Tumore Type, 2018-2023 ($)
Table 53: North America Personalized Medicines In Oncology Market, Revenue & Volume, By Service, 2018-2023 ($)
Table 54: North America Personalized Medicines In Oncology Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 55: North America Personalized Medicines In Oncology Market, Revenue & Volume, By Occurrence, 2018-2023 ($)
Table 56: North America Personalized Medicines In Oncology Market, Revenue & Volume, By End User, 2018-2023 ($)
Table 57: South america Personalized Medicines In Oncology Market, Revenue & Volume, By Tumore Type, 2018-2023 ($)
Table 58: South america Personalized Medicines In Oncology Market, Revenue & Volume, By Service, 2018-2023 ($)
Table 59: South america Personalized Medicines In Oncology Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 60: South america Personalized Medicines In Oncology Market, Revenue & Volume, By Occurrence, 2018-2023 ($)
Table 61: South america Personalized Medicines In Oncology Market, Revenue & Volume, By End User, 2018-2023 ($)
Table 62: Europe Personalized Medicines In Oncology Market, Revenue & Volume, By Tumore Type, 2018-2023 ($)
Table 63: Europe Personalized Medicines In Oncology Market, Revenue & Volume, By Service, 2018-2023 ($)
Table 64: Europe Personalized Medicines In Oncology Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 65: Europe Personalized Medicines In Oncology Market, Revenue & Volume, By Occurrence, 2018-2023 ($)
Table 66: Europe Personalized Medicines In Oncology Market, Revenue & Volume, By End User, 2018-2023 ($)
Table 67: APAC Personalized Medicines In Oncology Market, Revenue & Volume, By Tumore Type, 2018-2023 ($)
Table 68: APAC Personalized Medicines In Oncology Market, Revenue & Volume, By Service, 2018-2023 ($)
Table 69: APAC Personalized Medicines In Oncology Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 70: APAC Personalized Medicines In Oncology Market, Revenue & Volume, By Occurrence, 2018-2023 ($)
Table 71: APAC Personalized Medicines In Oncology Market, Revenue & Volume, By End User, 2018-2023 ($)
Table 72: Middle East & Africa Personalized Medicines In Oncology Market, Revenue & Volume, By Tumore Type, 2018-2023 ($)
Table 73: Middle East & Africa Personalized Medicines In Oncology Market, Revenue & Volume, By Service, 2018-2023 ($)
Table 74: Middle East & Africa Personalized Medicines In Oncology Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 75: Middle East & Africa Personalized Medicines In Oncology Market, Revenue & Volume, By Occurrence, 2018-2023 ($)
Table 76: Middle East & Africa Personalized Medicines In Oncology Market, Revenue & Volume, By End User, 2018-2023 ($)
Table 77: Russia Personalized Medicines In Oncology Market, Revenue & Volume, By Tumore Type, 2018-2023 ($)
Table 78: Russia Personalized Medicines In Oncology Market, Revenue & Volume, By Service, 2018-2023 ($)
Table 79: Russia Personalized Medicines In Oncology Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 80: Russia Personalized Medicines In Oncology Market, Revenue & Volume, By Occurrence, 2018-2023 ($)
Table 81: Russia Personalized Medicines In Oncology Market, Revenue & Volume, By End User, 2018-2023 ($)
Table 82: Israel Personalized Medicines In Oncology Market, Revenue & Volume, By Tumore Type, 2018-2023 ($)
Table 83: Israel Personalized Medicines In Oncology Market, Revenue & Volume, By Service, 2018-2023 ($)
Table 84: Israel Personalized Medicines In Oncology Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 85: Israel Personalized Medicines In Oncology Market, Revenue & Volume, By Occurrence, 2018-2023 ($)
Table 86: Israel Personalized Medicines In Oncology Market, Revenue & Volume, By End User, 2018-2023 ($)
Table 87: Top Companies 2017 (US$)Personalized Medicines In Oncology Market, Revenue & Volume
Table 88: Product Launch 2017-2018Personalized Medicines In Oncology Market, Revenue & Volume
Table 89: Mergers & Acquistions 2017-2018Personalized Medicines In Oncology Market, Revenue & Volume


List of Figures

Figure 1: Overview of Personalized Medicines In Oncology Market 2017-2023
Figure 2: Market Share Analysis for Personalized Medicines In Oncology Market 2017 (US$)
Figure 3: Product Comparison in Personalized Medicines In Oncology Market 2017-2018 (US$)
Figure 4: End User Profile for Personalized Medicines In Oncology Market 2017-2018 (US$)
Figure 5: Patent Application and Grant in Personalized Medicines In Oncology Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Personalized Medicines In Oncology Market 2017-2018 (US$)
Figure 7: Market Entry Strategy in Personalized Medicines In Oncology Market 2017-2018
Figure 8: Ecosystem Analysis in Personalized Medicines In Oncology Market 2017
Figure 9: Average Selling Price in Personalized Medicines In Oncology Market 2017-2023
Figure 10: Top Opportunites in Personalized Medicines In Oncology Market 2017-2018
Figure 11: Market Life Cycle Analysis in Personalized Medicines In Oncology Market Market Life Cycle Analysis in 3D Printing
Figure 12: GlobalBy Tumore TypePersonalized Medicines In Oncology Market Revenue, 2018-2023 ($)
Figure 13: GlobalBy ServicePersonalized Medicines In Oncology Market Revenue, 2018-2023 ($)
Figure 14: GlobalBy TechnologyPersonalized Medicines In Oncology Market Revenue, 2018-2023 ($)
Figure 15: GlobalBy OccurrencePersonalized Medicines In Oncology Market Revenue, 2018-2023 ($)
Figure 16: GlobalBy End UserPersonalized Medicines In Oncology Market Revenue, 2018-2023 ($)
Figure 17: Global Personalized Medicines In Oncology Market - By Geography
Figure 18: Global Personalized Medicines In Oncology Market Value & Volume, By Geography, 2018-2023 ($) 
Figure 19: Global Personalized Medicines In Oncology Market CAGR, By Geography, 2018-2023 (%)
Figure 20: North America Personalized Medicines In Oncology Market Value & Volume, 2018-2023 ($)
Figure 21: US Personalized Medicines In Oncology Market Value & Volume, 2018-2023 ($)
Figure 22: US GDP and Population, 2017-2018 ($)
Figure 23: US GDP – Composition of 2017, By Sector of Origin
Figure 24: US Export and Import Value & Volume, 2017-2018 ($)
Figure 25: Canada Personalized Medicines In Oncology Market Value & Volume, 2018-2023 ($)
Figure 26: Canada GDP and Population, 2017-2018 ($)
Figure 27: Canada GDP – Composition of 2017, By Sector of Origin
Figure 28: Canada Export and Import Value & Volume, 2017-2018 ($)
Figure 29: Mexico Personalized Medicines In Oncology Market Value & Volume, 2018-2023 ($)
Figure 30: Mexico GDP and Population, 2017-2018 ($)
Figure 31: Mexico GDP – Composition of 2017, By Sector of Origin
Figure 32: Mexico Export and Import Value & Volume, 2017-2018 ($)
Figure 33: South America Personalized Medicines In Oncology Market South America 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 34: Brazil Personalized Medicines In Oncology Market Value & Volume, 2018-2023 ($)
Figure 35: Brazil GDP and Population, 2017-2018 ($)
Figure 36: Brazil GDP – Composition of 2017, By Sector of Origin
Figure 37: Brazil Export and Import Value & Volume, 2017-2018 ($)
Figure 38: Venezuela Personalized Medicines In Oncology Market Value & Volume, 2018-2023 ($)
Figure 39: Venezuela GDP and Population, 2017-2018 ($)
Figure 40: Venezuela GDP – Composition of 2017, By Sector of Origin
Figure 41: Venezuela Export and Import Value & Volume, 2017-2018 ($)
Figure 42: Argentina Personalized Medicines In Oncology Market Value & Volume, 2018-2023 ($)
Figure 43: Argentina GDP and Population, 2017-2018 ($)
Figure 44: Argentina GDP – Composition of 2017, By Sector of Origin
Figure 45: Argentina Export and Import Value & Volume, 2017-2018 ($)
Figure 46: Ecuador Personalized Medicines In Oncology Market Value & Volume, 2018-2023 ($)
Figure 47: Ecuador GDP and Population, 2017-2018 ($)
Figure 48: Ecuador GDP – Composition of 2017, By Sector of Origin
Figure 49: Ecuador Export and Import Value & Volume, 2017-2018 ($)
Figure 50: Peru Personalized Medicines In Oncology Market Value & Volume, 2018-2023 ($)
Figure 51: Peru GDP and Population, 2017-2018 ($)
Figure 52: Peru GDP – Composition of 2017, By Sector of Origin
Figure 53: Peru Export and Import Value & Volume, 2017-2018 ($)
Figure 54: Colombia Personalized Medicines In Oncology Market Value & Volume, 2018-2023 ($)
Figure 55: Colombia GDP and Population, 2017-2018 ($)
Figure 56: Colombia GDP – Composition of 2017, By Sector of Origin
Figure 57: Colombia Export and Import Value & Volume, 2017-2018 ($)
Figure 58: Costa Rica Personalized Medicines In Oncology Market Costa Rica 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 59: Costa Rica GDP and Population, 2017-2018 ($)
Figure 60: Costa Rica GDP – Composition of 2017, By Sector of Origin
Figure 61: Costa Rica Export and Import Value & Volume, 2017-2018 ($)
Figure 62: Europe Personalized Medicines In Oncology Market Value & Volume, 2018-2023 ($)
Figure 63: U.K Personalized Medicines In Oncology Market Value & Volume, 2018-2023 ($)
Figure 64: U.K GDP and Population, 2017-2018 ($)
Figure 65: U.K GDP – Composition of 2017, By Sector of Origin
Figure 66: U.K Export and Import Value & Volume, 2017-2018 ($)
Figure 67: Germany Personalized Medicines In Oncology Market Value & Volume, 2018-2023 ($)
Figure 68: Germany GDP and Population, 2017-2018 ($)
Figure 69: Germany GDP – Composition of 2017, By Sector of Origin
Figure 70: Germany Export and Import Value & Volume, 2017-2018 ($)
Figure 71: Italy Personalized Medicines In Oncology Market Value & Volume, 2018-2023 ($)
Figure 72: Italy GDP and Population, 2017-2018 ($)
Figure 73: Italy GDP – Composition of 2017, By Sector of Origin
Figure 74: Italy Export and Import Value & Volume, 2017-2018 ($)
Figure 75: France Personalized Medicines In Oncology Market Value & Volume, 2018-2023 ($)
Figure 76: France GDP and Population, 2017-2018 ($)
Figure 77: France GDP – Composition of 2017, By Sector of Origin
Figure 78: France Export and Import Value & Volume, 2017-2018 ($)
Figure 79: Netherlands Personalized Medicines In Oncology Market Value & Volume, 2018-2023 ($)
Figure 80: Netherlands GDP and Population, 2017-2018 ($)
Figure 81: Netherlands GDP – Composition of 2017, By Sector of Origin
Figure 82: Netherlands Export and Import Value & Volume, 2017-2018 ($)
Figure 83: Belgium Personalized Medicines In Oncology Market Value & Volume, 2018-2023 ($)
Figure 84: Belgium GDP and Population, 2017-2018 ($)
Figure 85: Belgium GDP – Composition of 2017, By Sector of Origin
Figure 86: Belgium Export and Import Value & Volume, 2017-2018 ($)
Figure 87: Spain Personalized Medicines In Oncology Market Value & Volume, 2018-2023 ($)
Figure 88: Spain GDP and Population, 2017-2018 ($)
Figure 89: Spain GDP – Composition of 2017, By Sector of Origin
Figure 90: Spain Export and Import Value & Volume, 2017-2018 ($)
Figure 91: Denmark Personalized Medicines In Oncology Market Value & Volume, 2018-2023 ($)
Figure 92: Denmark GDP and Population, 2017-2018 ($)
Figure 93: Denmark GDP – Composition of 2017, By Sector of Origin
Figure 94: Denmark Export and Import Value & Volume, 2017-2018 ($)
Figure 95: APAC Personalized Medicines In Oncology Market Value & Volume, 2018-2023 ($)
Figure 96: China Personalized Medicines In Oncology Market Value & Volume, 2018-2023
Figure 97: China GDP and Population, 2017-2018 ($)
Figure 98: China GDP – Composition of 2017, By Sector of Origin
Figure 99: China Export and Import Value & Volume, 2017-2018 ($)Personalized Medicines In Oncology Market China Export and Import Value & Volume, 2017-2018 ($)
Figure 100: Australia Personalized Medicines In Oncology Market Value & Volume, 2018-2023 ($)
Figure 101: Australia GDP and Population, 2017-2018 ($)
Figure 102: Australia GDP – Composition of 2017, By Sector of Origin
Figure 103: Australia Export and Import Value & Volume, 2017-2018 ($)
Figure 104: South Korea Personalized Medicines In Oncology Market Value & Volume, 2018-2023 ($)
Figure 105: South Korea GDP and Population, 2017-2018 ($)
Figure 106: South Korea GDP – Composition of 2017, By Sector of Origin
Figure 107: South Korea Export and Import Value & Volume, 2017-2018 ($)
Figure 108: India Personalized Medicines In Oncology Market Value & Volume, 2018-2023 ($)
Figure 109: India GDP and Population, 2017-2018 ($)
Figure 110: India GDP – Composition of 2017, By Sector of Origin
Figure 111: India Export and Import Value & Volume, 2017-2018 ($)
Figure 112: Taiwan Personalized Medicines In Oncology Market Taiwan 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 113: Taiwan GDP and Population, 2017-2018 ($)
Figure 114: Taiwan GDP – Composition of 2017, By Sector of Origin
Figure 115: Taiwan Export and Import Value & Volume, 2017-2018 ($)
Figure 116: Malaysia Personalized Medicines In Oncology Market Malaysia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 117: Malaysia GDP and Population, 2017-2018 ($)
Figure 118: Malaysia GDP – Composition of 2017, By Sector of Origin
Figure 119: Malaysia Export and Import Value & Volume, 2017-2018 ($)
Figure 120: Hong Kong Personalized Medicines In Oncology Market Hong Kong 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 121: Hong Kong GDP and Population, 2017-2018 ($)
Figure 122: Hong Kong GDP – Composition of 2017, By Sector of Origin
Figure 123: Hong Kong Export and Import Value & Volume, 2017-2018 ($)
Figure 124: Middle East & Africa Personalized Medicines In Oncology Market Middle East & Africa 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 125: Russia Personalized Medicines In Oncology Market Russia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 126: Russia GDP and Population, 2017-2018 ($)
Figure 127: Russia GDP – Composition of 2017, By Sector of Origin
Figure 128: Russia Export and Import Value & Volume, 2017-2018 ($)
Figure 129: Israel Personalized Medicines In Oncology Market Value & Volume, 2018-2023 ($)
Figure 130: Israel GDP and Population, 2017-2018 ($)
Figure 131: Israel GDP – Composition of 2017, By Sector of Origin
Figure 132: Israel Export and Import Value & Volume, 2017-2018 ($)
Figure 133: Entropy Share, By Strategies, 2017-2018* (%)Personalized Medicines In Oncology Market
Figure 134: Developments, 2017-2018*Personalized Medicines In Oncology Market
Figure 135: Company 1 Personalized Medicines In Oncology Market Net Revenue, By Years, 2017-2018* ($)
Figure 136: Company 1 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2017 (%)
Figure 137: Company 1 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2017 (%)
Figure 138: Company 2 Personalized Medicines In Oncology Market Net Revenue, By Years, 2017-2018* ($)
Figure 139: Company 2 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2017 (%)
Figure 140: Company 2 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2017 (%)
Figure 141: Company 3 Personalized Medicines In Oncology Market Net Revenue, By Years, 2017-2018* ($)
Figure 142: Company 3 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2017 (%)
Figure 143: Company 3 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2017 (%)
Figure 144: Company 4 Personalized Medicines In Oncology Market Net Revenue, By Years, 2017-2018* ($)
Figure 145: Company 4 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2017 (%)
Figure 146: Company 4 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2017 (%)
Figure 147: Company 5 Personalized Medicines In Oncology Market Net Revenue, By Years, 2017-2018* ($)
Figure 148: Company 5 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2017 (%)
Figure 149: Company 5 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2017 (%)
Figure 150: Company 6 Personalized Medicines In Oncology Market Net Revenue, By Years, 2017-2018* ($)
Figure 151: Company 6 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2017 (%)
Figure 152: Company 6 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2017 (%)
Figure 153: Company 7 Personalized Medicines In Oncology Market Net Revenue, By Years, 2017-2018* ($)
Figure 154: Company 7 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2017 (%)
Figure 155: Company 7 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2017 (%)
Figure 156: Company 8 Personalized Medicines In Oncology Market Net Revenue, By Years, 2017-2018* ($)
Figure 157: Company 8 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2017 (%)
Figure 158: Company 8 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2017 (%)
Figure 159: Company 9 Personalized Medicines In Oncology Market Net Revenue, By Years, 2017-2018* ($)
Figure 160: Company 9 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2017 (%)
Figure 161: Company 9 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2017 (%)
Figure 162: Company 10 Personalized Medicines In Oncology Market Net Revenue, By Years, 2017-2018* ($)
Figure 163: Company 10 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2017 (%)
Figure 164: Company 10 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2017 (%)
Figure 165: Company 11 Personalized Medicines In Oncology Market Net Revenue, By Years, 2017-2018* ($)
Figure 166: Company 11 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2017 (%)
Figure 167: Company 11 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2017 (%)
Figure 168: Company 12 Personalized Medicines In Oncology Market Net Revenue, By Years, 2017-2018* ($)
Figure 169: Company 12 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2017 (%)
Figure 170: Company 12 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2017 (%)
Figure 171: Company 13 Personalized Medicines In Oncology Market Net Revenue, By Years, 2017-2018* ($)
Figure 172: Company 13 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2017 (%)
Figure 173: Company 13 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2017 (%)
Figure 174: Company 14 Personalized Medicines In Oncology Market Net Revenue, By Years, 2017-2018* ($)
Figure 175: Company 14 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2017 (%)
Figure 176: Company 14 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2017 (%)
Figure 177: Company 15 Personalized Medicines In Oncology Market Net Revenue, By Years, 2017-2018* ($)
Figure 178: Company 15 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2017 (%)
Figure 179: Company 15 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2017 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll